Edition:
India

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

105.10EUR
14 Dec 2017
Change (% chg)

€-1.30 (-1.22%)
Prev Close
€106.40
Open
€105.75
Day's High
€106.20
Day's Low
€105.00
Volume
2,610,049
Avg. Vol
1,851,783
52-wk High
€123.90
52-wk Low
€95.46

Select another date:

Mon, Dec 11 2017

BRIEF-Bayer's Rivaroxaban Submitted To U.S. FDA For Approval

* RIVAROXABAN SUBMITTED TO U.S. FDA FOR APPROVAL IN PATIENTS WITH CORONARY AND/OR PERIPHERAL ARTERY DISEASE Source text - http://bit.ly/2B4uKdl Further company coverage: (Gdynia Newsroom)

EU regulators to warn Bayer about Monsanto bid: source

BRUSSELS EU antitrust regulators are set to warn Bayer its planned purchase of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday, a move that would force Bayer to offer concessions to address the concerns.

EU regulators to warn Bayer about Monsanto bid -source

BRUSSELS EU antitrust regulators are set to warn Bayer its planned purchase of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday, a move that would force Bayer to offer concessions to address the concerns.

UPDATE 2-EU regulators to warn Bayer about Monsanto bid -source

BRUSSELS, Dec 8 EU antitrust regulators are set to warn Bayer its planned purchase of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday, a move that would force Bayer to offer concessions to address the concerns.

EU regulators to warn Bayer about Monsanto bid - source

BRUSSELS, Dec 8 EU antitrust regulators are expected to warn Bayer in the coming weeks that its planned takeover of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday.

Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

UPDATE 1-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

Dec 5 A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

CORRECTED-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

Dec 5 A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks by its blockbuster drug Xarelto.

BRIEF-Bayer: Updated Clinical Data From Larotrectinib Pediatric Phase I SCOUT Trial

* ‍UPDATED LAROTRECTINIB PEDIATRIC CLINICAL TRIAL DATA DEMONSTRATE CONTINUED DURABILITY OF RESPONSE IN TRK FUSION CANCERS​ Source text for Eikon: [ID:http://bit.ly/2iJSOeQ] Further company coverage: (Gdynia Newsroom)

Bayer sticks to bone metastasis drug estimate after setback

BERLIN, Dec 1 Bayer is sticking to its peak sales estimate for bone metastasis drug Xofigo despite a setback in a late-stage drug trial, the head of the German group's pharmaceuticals unit said on Friday.

Select another date: